NMPA Approval

Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets (15mg/500mg)

Approval Number

国药准字H20253648

Company寿光富康制药有限公司

Registration Date

March 18, 2025

Drug Information

Generic Name

吡格列酮二甲双胍片

Dosage Form

片剂

Strength

每片含盐酸吡格列酮15mg（以C₁₉H₂₀N₂O₃S计）和盐酸二甲双胍500mg。

Drug Type

化学药品

Registration Date

March 18, 2025

Company Information

Applicant Company

Company Name寿光富康制药有限公司

Company Address

山东省寿光市东环路666号

Manufacturing Company

Company Name寿光富康制药有限公司

Company Address

寿光市文圣东街999号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

吡格列酮二甲双胍片 - NMPA 批准文号 | MedPath